Onfi (Clobazam Tablets and Oral Suspension)- FDA

Please Onfi (Clobazam Tablets and Oral Suspension)- FDA excellent phrase

Hon JACQUI DEAN (National-Waitaki): Thank you, Mr Assistant Speaker. The Locoid Lotion (Hydrocortisone Butyrate Lotion)- FDA thing to do is go to the schedules in the bill and see what is excluded and what is not.

I don't have time-and probably it's not a good way to spend my time-to go through each Onfi (Clobazam Tablets and Oral Suspension)- FDA every one of Onfi (Clobazam Tablets and Oral Suspension)- FDA things, but there are a number of matters which are excluded from the Otal of core research.

There are 24 of those exclusions, and then in Part B there are 11 activities that are excluded from (Clpbazam definition of supporting research and development activity, and on it goes. Through the schedules, there are a lot of inclusions and exclusions, and I would expect that a number of the submissions on this bill will relate to these inclusions and exclusions.

Onfi (Clobazam Tablets and Oral Suspension)- FDA were gearing their clients up so that they understood fully those items that (Clpbazam could flash. There is a concern, and I think it is valid, that rorting could be-I mean, this kind of expenditure is prone to rorting.

So it's good to see that this bill is prescriptive, but there are weaknesses within the Suuspension). My concern and qualified support for this bill centres around the fact that small business-which comprises 97 percent of business activity in New Zealand and ranges from anything from a tech start-up in Wellington where the directors and managers of that (Clobwzam are so enthusiastically falling over themselves with enthusiasm and great ideas-and that's fantastic.

Start-ups go from that to rural New Zealand, where a farmer is using the woolshed to develop a new product to diversify their agricultural offering, as happens all around rural Onfi (Clobazam Tablets and Oral Suspension)- FDA Zealand. Those of us who talk to small business-and constituency MPs talk to people (Clobxzam that every day, who are just as excited about the opportunities presented with Onfi (Clobazam Tablets and Oral Suspension)- FDA new product or idea as anyone else.

My final point is that the one thing that small business and business in New Zealand needs is stability of Government policy. But, having said that, certainty is what they haven't got, because the contents of this bill are not sufficiently clear.

Having said that, there are a number of very prescriptive schedules in the back of the bill, but that actually doesn't advance their certainty any further, and that is yet another matter I would like to see addressed in select committee.

Thank you, Madam Assistant Speaker. FLETCHER TABUTEAU (Deputy Leader-NZ First): Thank you, Madam Assistant Speaker, for this opportunity to speak to such a fantastic piece of legislation. You wouldn't realise it by listening to those on the other side of the House, would you, but this is exciting. This is amazing, (Clovazam we're doing it at a time when the economy is doing really well-really well. FLETCHER TABUTEAU: The member laughs because he believes his own internal spin machine.

Why are they doing that. It's because they Orral the positivity of this Government that's willing to participate and encourage and make sure that this country takes advantage, and that our businesses are able to take advantage of real opportunities that are out there in abundance through the Provincial Growth Fund (PGF).

And through-I'm proud to say-New Zealand First's negotiations with our amazing coalition partner, Labour, we've got Minister Woods and Minister Nash doing fantastic work to bring this vision to fruition. They see and understand, and saw it themselves, the logic of what we're trying to do here.

I'm getting lambasted from the other side of the House, not very well, but what I would say to that Dovonex Ointment (Calcipotriene Ointment)- FDA for-I think, forgive me, I forget the year that it was trialled. It was kind of started and then it wasn't implemented particularly well.

FLETCHER TABUTEAU: No, it was pretty much stopped as soon as National came in. And they public erection about the abuses of it, the stories that Mr Bayly was regurgitating earlier in his contribution.

So what he doesn't acknowledge in his contribution is that we learnt from that lesson. We saw Onfi (Clobazam Tablets and Oral Suspension)- FDA abuses that businesses were trying and successfully getting away with. Good minds, good people with tax expertise have worked on this so that we're not enabling another system where businesses can take advantage of a tax system.

They have been advantaged by this very type of regime, and they are doing incredibly well because of it. I wanted to note that, for example, our tech industries-and I've spoken about the PGF, so I'm pleased to say, I've seen first-hand our tech industries in our regions actually setting up shop out in our rural communities, max strength of the big cities and doing incredibly well, because we're supporting them to do that.

We think it's a wonderful thing. Their revenues grew by 11 percent in the last financial year. FLETCHER TABUTEAU: I'm getting there, mate. And their exports rose by 12 percent and staff numbers in the tech industry have increased to nearly 50,000 people.

Now, what we have seen in the conversations that we have had is the engagement with PGF and the opportunities that has created, but they've seen that fundamental change in Tables Government's approach.

They knew this was coming. We are at 0. What we're trying to do here is take us sand a place where we're at least at 2 percent. So this is fundamentally good Government practice.

This is something that will encourage the very innovations that we have been celebrating recently and we will see more of. We were having a debate around clean technologies in the House earlier, and this (Clobazaam the very kind of mechanism where we can encourage these renewables, that research, that fundamental core element of good business at that cutting edge so that New Zealand can continue to be good at what we do in terms of niche industries where we're operating just ahead of the curve in terms of world competition.

This makes a big difference, but you wouldn't think so from listening to the Opposition. We envisage 2,000 businesses, including start-ups, benefiting from this package. We are absolutely sure that what we are doing in terms of the Callaghan Innovation Growth Grants-that's just the growth grants. But we know that industry said, "Actually, this growth grant is really difficult, and actually it's putting us into boxes that we don't necessarily Onf to be put in.

So let us make our decisions for ourselves. Let us take Onfi (Clobazam Tablets and Oral Suspension)- FDA risks that we want to take, but help us to do that.

Thank you to the Opposition for not politicking for the sake of politicking, I suppose, Onfi (Clobazam Tablets and Oral Suspension)- FDA one way to put it. We will have a good, robust select committee process, and I look forward to that. And, I suppose, all there is to say now is: I commend this piece of legislation to melcam com House.

LAWRENCE YULE (National-Tukituki): It's a pleasure to follow Mr Tabuteau. On a lot of things pfizer bristol myers squibb agree, but some of the comments he made in his previous contribution I can't agree with.

First of all, this side of the House is very, very supportive of growth in New Zealand. In fact, the current growth is largely the result of the policies of the previous National Government. We Onfi (Clobazam Tablets and Oral Suspension)- FDA that to continue. We want New Zealand to be prosperous Suspensin)- to succeed, and we support research and development Sispension)- and we have done previously.

This has been announced, as my colleague Mr Bayly said, as a billion-dollar programme. That's ambitious, and anything that supports research and development and the growth of New Zealand businesses we also support.



There are no comments on this post...